Guangzhou Zhiyi Biotechnology Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Guangzhou Zhiyi Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis (NCT06725017) | Guangzhou Zhiyi Biotechnology Co., Ltd. | 2025-07-01 |
| A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D (NCT06247046) | Guangzhou Zhiyi Biotechnology Co., Ltd. | 2024-03-16 |
| A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects (NCT06026397) | Guangzhou Zhiyi Biotechnology Co., Ltd. | 2023-08-01 |
Track Guangzhou Zhiyi Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.